aurisco pharmaceutical co., ltd.-fun88官网
about
us
r&d
product
&
service
manufacturing
site
investor
relations
career
contact
us
fun88官网-fun88登录
api
fdf
oligonucleotide cro&cdmo
tech platforms
enzalutamide tablets
strength：
40mg, 80mg
indication：
castration-resistant prostate cancer (crpc); metastatic castration-sensitive prostate cancer (mcspc).
网站地图
